Microbot Medical MBOT Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $105K— | —— | —— | —— | —— | ||
| $103K— | —— | —— | —— | —— | ||
| $2K— | —— | —— | —— | —— | ||
| 1.9%— | —— | —— | —— | —— | ||
| $1.29M-11.4% | $1.54M-22.3% | $1.17M-43.2% | $2.11M+49.0% | $1.46M+24.8% | ||
| $3.03M+93.9% | —— | —— | —— | $1.56M+25.1% | ||
| -$4.32M-43.0% | -$4.14M-20.6% | -$3.86M-17.0% | -$3.72M-48.3% | -$3.02M-26.7% | ||
| -4,114.3%— | —— | —— | —— | —— | ||
| $649K+524% | $674K+1,674% | $284K+234% | $223K+385% | $104K+700% | ||
| —— | —— | —— | —— | $316K— | ||
| —— | 0%— | —— | —— | —— | ||
| -$3.67M-41.1% | -$3.46M-2.1% | -$3.58M-11.3% | -$3.5M-42.0% | -$2.6M-9.7% | ||
| -3,496.2%— | —— | —— | —— | —— | ||
| -$0.05+37.5% | -$0.04+80.0% | -$0.07+65.0% | -$0.10+41.2% | -$0.08+52.9% | ||
| -$4.31M-43.3% | -$4.13M-21.3% | -$3.85M-17.5% | -$3.71M-48.6% | -$3.01M-27.6% | ||
| -4,102.9%— | —— | —— | —— | —— | ||
| -$4.32M-43.0% | -$4.14M-20.6% | -$3.86M-17.0% | -$3.72M-48.3% | -$3.02M-26.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Microbot Medical's revenue?
- Microbot Medical (MBOT) generated $190.2K in revenue over the trailing twelve months, up 62.4% year over year.
- Is Microbot Medical profitable?
- Microbot Medical is not currently profitable: it reported a net loss of $14.2M over the trailing twelve months, a -3669.9% net margin.
- What is Microbot Medical's earnings per share?
- Microbot Medical's diluted EPS over the trailing twelve months is $-0.26.
- Where does Microbot Medical's income statement data come from?
- Every line is extracted from Microbot Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
